Overview

Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement

Status:
Recruiting
Trial end date:
2022-06-15
Target enrollment:
Participant gender:
Summary
The investigators aim to compare subacromial ketorolac (non-steroidal anti-inflammatory drug) versus methylprednisolone (steroid) for the treatment of shoulder impingement syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Treatments:
Ketorolac
Ketorolac Tromethamine
Lidocaine
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate